Related Experiment Video

Updated: Jan 28, 2026

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
11:21

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

10.4K

A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer

Natasha C Lucki1, Genaro R Villa2,3, Naja Vergani1,4

  • 1California Institute for Biomedical Research, La Jolla, CA 92037.

Proceedings of the National Academy of Sciences of the United States of America
|March 9, 2019
PubMed

Insights

Researchers discovered RIPGBM, a novel small molecule that selectively kills glioblastoma cancer stem cells (CSCs). This compound targets receptor-interacting protein kinase 2 (RIPK2), offering a promising new therapeutic strategy for aggressive brain tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Glioblastoma multiforme (GBM) is an aggressive primary brain cancer.
  • GBM cancer stem cells (CSCs) drive tumor growth, metastasis, and recurrence.
  • Effective treatments for GBM remain limited.

Purpose of the Study:

  • To identify novel small molecules targeting GBM CSCs.
  • To elucidate the mechanism of action for potential GBM therapeutics.
  • To evaluate the efficacy of identified compounds in preclinical models.

Main Methods:

  • Cell-based chemical screening to identify apoptosis-inducing compounds.
  • Characterization of small molecule derivatives and their mechanisms.
  • In vitro studies on patient-derived GBM CSCs.
  • In vivo evaluation using an orthotopic GBM CSC xenograft mouse model.

Main Results:

  • Identification of RIPGBM, a small molecule selectively inducing apoptosis in GBM CSCs.
  • Discovery of a redox-dependent proapoptotic derivative, cRIPGBM.
  • Mechanism involves RIPK2 modulation, shifting balance from prosurvival to proapoptotic complexes.
  • RIPGBM significantly suppressed tumor formation in a mouse model.

Conclusions:

  • RIPGBM is a promising drug candidate for glioblastoma treatment.
  • Targeting RIPK2 offers a novel therapeutic strategy for GBM.
  • This chemical genetics approach provides a foundation for developing new GBM therapies.
Keywords:
chemical geneticsglioblastomaphenotypic drug screeningreceptor-interacting protein kinase 2target identification

More Related Videos

Isolated Pancreatic Islet Treatment and Apoptosis Measurement09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

887
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

11.4K

Related Concept Videos

Types of Selection01:46

Types of Selection

Natural selection influences the frequencies of particular alleles and phenotypes within populations in several different ways. Primarily, natural selection can be directional, stabilizing, or disruptive. Directional selection favors one extreme trait and shifts the population towards that phenotype while selecting against individuals displaying alternate traits. Stabilizing selection favors an intermediate trait with a narrow range of variation. Deviation from the optimal phenotype towards an...
44.6K
Cell Adhesion Molecules - Types and Functions01:20

Cell Adhesion Molecules - Types and Functions

Cell adhesion molecules (CAMs) are pivotal to multicellularity and the coordinated functioning of tissues and organ systems. They enable physical interactions between cells and provide mechanical strength to tissues. They also function as receptors for signal transmission across the plasma membrane. The CAMs are broadly classified into four families - integrins, cadherins, selectins, and immunoglobulin-like CAMs (IgCAMs).
CAM Families
The Integrin family of proteins is primarily  involved...
9.3K
Types of Signaling Molecules01:32

Types of Signaling Molecules

In multicellular organisms, many molecules transmit signals between cells to pass information. These signals vary in complexity and include small peptides, nucleotides, steroids, fatty acid derivatives, and dissolved gases such as nitric oxide. Some signaling molecules diffuse through the plasma membrane to act locally between neighboring cells or travel long distances. Others remain attached to the cell surface, transmitting information to other cells only when they make contact. In some...
13.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.4K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K